+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Cyclo-oxygenase 2 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Cyclo-oxygenase 2 Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Xenotransplantation Market Report 2025 - Product Thumbnail Image

Xenotransplantation Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
From
Insomnia Therapeutics Market 2024-2028 - Product Thumbnail Image

Insomnia Therapeutics Market 2024-2028

  • Report
  • September 2024
  • 156 Pages
  • Global
From
Pompe Disease Drugs Market 2024-2028 - Product Thumbnail Image

Pompe Disease Drugs Market 2024-2028

  • Report
  • January 2024
  • 161 Pages
  • Global
From
From
Angina Pectoris Drugs Market Report 2025 - Product Thumbnail Image

Angina Pectoris Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
U.S. Gene Therapy Market - Industry Outlook & Forecast 2022-2027 - Product Thumbnail Image

U.S. Gene Therapy Market - Industry Outlook & Forecast 2022-2027

  • Report
  • March 2022
  • 208 Pages
  • United States
From
Cardiometabolic Diseases Market Report 2025 - Product Thumbnail Image

Cardiometabolic Diseases Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator